US Stock MarketDetailed Quotes

RTX RTX Corp

Watchlist
  • 122.410
  • -3.430-2.73%
Close Feb 14 16:00 ET
  • 122.000
  • -0.410-0.33%
Post 20:01 ET
163.07BMarket Cap34.48P/E (TTM)

RTX Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
17.15%80.74B
8.51%21.62B
49.21%20.09B
7.68%19.72B
12.15%19.31B
2.75%68.92B
10.14%19.93B
-20.57%13.46B
12.27%18.32B
9.53%17.21B
Operating revenue
17.15%80.74B
8.51%21.62B
49.21%20.09B
7.68%19.72B
12.15%19.31B
2.75%68.92B
10.14%19.93B
-20.57%13.46B
12.27%18.32B
9.53%17.21B
Cost of revenue
14.95%65.33B
9.23%17.39B
25.92%16.06B
11.18%16.14B
15.38%15.74B
6.41%56.83B
9.58%15.92B
-5.30%12.75B
12.93%14.52B
8.64%13.65B
Gross profit
27.47%15.41B
5.64%4.24B
464.99%4.03B
-5.72%3.58B
-0.22%3.56B
-11.55%12.09B
12.39%4.01B
-79.52%714M
9.80%3.8B
13.09%3.57B
Operating expense
4.03%8.87B
-4.84%2.12B
-4.93%2.01B
32.42%3.05B
-10.15%1.69B
4.46%8.53B
7.51%2.23B
7.27%2.11B
9.45%2.3B
-9.34%1.88B
Selling and administrative expenses
-0.05%5.81B
8.93%1.57B
-0.86%1.39B
-9.44%1.45B
2.27%1.39B
4.23%5.81B
4.03%1.45B
3.70%1.4B
12.36%1.6B
-7.22%1.36B
Research and development costs
4.60%2.93B
6.74%808M
5.48%751M
-3.16%706M
10.21%669M
3.47%2.81B
5.73%757M
7.55%712M
4.44%729M
-4.41%607M
Other operating expenses
253.49%132M
-960.00%-258M
-4,366.67%-134M
3,684.00%896M
-322.73%-372M
28.33%-86M
203.45%30M
93.48%-3M
-47.06%-25M
-214.29%-88M
Operating profit
83.60%6.54B
18.80%2.11B
245.27%2.03B
-64.57%529M
10.85%1.87B
-35.30%3.56B
19.18%1.78B
-191.84%-1.4B
10.35%1.49B
56.20%1.69B
Net non-operating interest income expense
-20.28%-1.87B
2.01%-487M
-35.22%-503M
-32.11%-469M
-24.32%-409M
-26.26%-1.55B
-57.28%-497M
-17.72%-372M
-15.64%-355M
-13.06%-329M
Non-operating interest income
2.00%102M
-50.00%27M
136.84%45M
11.76%19M
10.00%11M
42.86%100M
237.50%54M
90.00%19M
30.77%17M
-67.74%10M
Non-operating interest expense
19.18%1.97B
-6.72%514M
40.15%548M
31.18%488M
23.89%420M
27.15%1.65B
65.96%551M
19.94%391M
16.25%372M
5.28%339M
Other net income (expense)
-16.63%1.52B
-15.38%385M
-14.57%381M
-21.54%368M
-14.85%390M
-0.81%1.83B
-2.15%455M
-5.71%446M
3.76%469M
1.10%458M
Other non- operating income (expenses)
-16.63%1.52B
-15.38%385M
-14.57%381M
-21.54%368M
-14.85%390M
-0.81%1.83B
-2.15%455M
-5.71%446M
3.76%469M
1.10%458M
Income before tax
61.47%6.19B
15.79%2.01B
244.18%1.91B
-73.37%428M
1.93%1.85B
-37.29%3.84B
5.79%1.74B
-178.83%-1.32B
7.28%1.61B
46.22%1.82B
Income tax
158.99%1.18B
71.37%449M
195.37%371M
2.02%253M
-67.76%108M
-42.28%456M
52.33%262M
-237.94%-389M
55.00%248M
188.79%335M
Net income
48.31%5.01B
5.91%1.56B
264.52%1.54B
-87.12%175M
17.69%1.74B
-36.32%3.38B
0.34%1.47B
-166.88%-933M
1.57%1.36B
33.79%1.48B
Net income continuous Operations
48.31%5.01B
5.91%1.56B
264.52%1.54B
-87.12%175M
17.69%1.74B
-36.55%3.38B
0.34%1.47B
-166.88%-933M
1.57%1.36B
31.53%1.48B
Net income discontinuous operations
--0
----
----
----
----
--0
----
----
----
----
Minority interest income
29.19%239M
65.96%78M
23.53%63M
100.00%64M
-38.18%34M
66.67%185M
2.17%47M
537.50%51M
-5.88%32M
139.13%55M
Net income attributable to the parent company
49.42%4.77B
3.93%1.48B
249.59%1.47B
-91.64%111M
19.85%1.71B
-38.52%3.2B
0.28%1.43B
-170.94%-984M
1.76%1.33B
31.55%1.43B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.42%4.77B
3.93%1.48B
249.59%1.47B
-91.64%111M
19.85%1.71B
-38.52%3.2B
0.28%1.43B
-170.94%-984M
1.76%1.33B
31.55%1.43B
Basic earnings per share
59.82%3.58
5.71%1.11
261.76%1.1
-91.21%0.08
31.63%1.29
-36.36%2.24
8.25%1.05
-172.34%-0.68
3.41%0.91
34.25%0.98
Diluted earnings per share
59.19%3.55
4.76%1.1
260.29%1.09
-91.11%0.08
31.96%1.28
-36.29%2.23
9.38%1.05
-172.34%-0.68
2.27%0.9
34.72%0.97
Dividend per share
6.90%2.48
6.78%0.63
6.78%0.63
6.78%0.63
7.27%0.59
7.41%2.32
7.27%0.59
7.27%0.59
7.27%0.59
7.84%0.55
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 17.15%80.74B8.51%21.62B49.21%20.09B7.68%19.72B12.15%19.31B2.75%68.92B10.14%19.93B-20.57%13.46B12.27%18.32B9.53%17.21B
Operating revenue 17.15%80.74B8.51%21.62B49.21%20.09B7.68%19.72B12.15%19.31B2.75%68.92B10.14%19.93B-20.57%13.46B12.27%18.32B9.53%17.21B
Cost of revenue 14.95%65.33B9.23%17.39B25.92%16.06B11.18%16.14B15.38%15.74B6.41%56.83B9.58%15.92B-5.30%12.75B12.93%14.52B8.64%13.65B
Gross profit 27.47%15.41B5.64%4.24B464.99%4.03B-5.72%3.58B-0.22%3.56B-11.55%12.09B12.39%4.01B-79.52%714M9.80%3.8B13.09%3.57B
Operating expense 4.03%8.87B-4.84%2.12B-4.93%2.01B32.42%3.05B-10.15%1.69B4.46%8.53B7.51%2.23B7.27%2.11B9.45%2.3B-9.34%1.88B
Selling and administrative expenses -0.05%5.81B8.93%1.57B-0.86%1.39B-9.44%1.45B2.27%1.39B4.23%5.81B4.03%1.45B3.70%1.4B12.36%1.6B-7.22%1.36B
Research and development costs 4.60%2.93B6.74%808M5.48%751M-3.16%706M10.21%669M3.47%2.81B5.73%757M7.55%712M4.44%729M-4.41%607M
Other operating expenses 253.49%132M-960.00%-258M-4,366.67%-134M3,684.00%896M-322.73%-372M28.33%-86M203.45%30M93.48%-3M-47.06%-25M-214.29%-88M
Operating profit 83.60%6.54B18.80%2.11B245.27%2.03B-64.57%529M10.85%1.87B-35.30%3.56B19.18%1.78B-191.84%-1.4B10.35%1.49B56.20%1.69B
Net non-operating interest income expense -20.28%-1.87B2.01%-487M-35.22%-503M-32.11%-469M-24.32%-409M-26.26%-1.55B-57.28%-497M-17.72%-372M-15.64%-355M-13.06%-329M
Non-operating interest income 2.00%102M-50.00%27M136.84%45M11.76%19M10.00%11M42.86%100M237.50%54M90.00%19M30.77%17M-67.74%10M
Non-operating interest expense 19.18%1.97B-6.72%514M40.15%548M31.18%488M23.89%420M27.15%1.65B65.96%551M19.94%391M16.25%372M5.28%339M
Other net income (expense) -16.63%1.52B-15.38%385M-14.57%381M-21.54%368M-14.85%390M-0.81%1.83B-2.15%455M-5.71%446M3.76%469M1.10%458M
Other non- operating income (expenses) -16.63%1.52B-15.38%385M-14.57%381M-21.54%368M-14.85%390M-0.81%1.83B-2.15%455M-5.71%446M3.76%469M1.10%458M
Income before tax 61.47%6.19B15.79%2.01B244.18%1.91B-73.37%428M1.93%1.85B-37.29%3.84B5.79%1.74B-178.83%-1.32B7.28%1.61B46.22%1.82B
Income tax 158.99%1.18B71.37%449M195.37%371M2.02%253M-67.76%108M-42.28%456M52.33%262M-237.94%-389M55.00%248M188.79%335M
Net income 48.31%5.01B5.91%1.56B264.52%1.54B-87.12%175M17.69%1.74B-36.32%3.38B0.34%1.47B-166.88%-933M1.57%1.36B33.79%1.48B
Net income continuous Operations 48.31%5.01B5.91%1.56B264.52%1.54B-87.12%175M17.69%1.74B-36.55%3.38B0.34%1.47B-166.88%-933M1.57%1.36B31.53%1.48B
Net income discontinuous operations --0------------------0----------------
Minority interest income 29.19%239M65.96%78M23.53%63M100.00%64M-38.18%34M66.67%185M2.17%47M537.50%51M-5.88%32M139.13%55M
Net income attributable to the parent company 49.42%4.77B3.93%1.48B249.59%1.47B-91.64%111M19.85%1.71B-38.52%3.2B0.28%1.43B-170.94%-984M1.76%1.33B31.55%1.43B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.42%4.77B3.93%1.48B249.59%1.47B-91.64%111M19.85%1.71B-38.52%3.2B0.28%1.43B-170.94%-984M1.76%1.33B31.55%1.43B
Basic earnings per share 59.82%3.585.71%1.11261.76%1.1-91.21%0.0831.63%1.29-36.36%2.248.25%1.05-172.34%-0.683.41%0.9134.25%0.98
Diluted earnings per share 59.19%3.554.76%1.1260.29%1.09-91.11%0.0831.96%1.28-36.29%2.239.38%1.05-172.34%-0.682.27%0.934.72%0.97
Dividend per share 6.90%2.486.78%0.636.78%0.636.78%0.637.27%0.597.41%2.327.27%0.597.27%0.597.27%0.597.84%0.55
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!